Maryland Ozempic Price Cap: The $274 Limit, Explained
Maryland is the first state to cap what its government health plans pay for Ozempic. On November 16, 2026, the state's Prescription Drug Affordability Board gave final approval to a limit of $274 for a 30-day supply, the same price Medicare negotiated for 2027. State and local government plans can use it from January 1, 2027, and must use it after January 1, 2028; it does not set your copay and does not cover Wegovy. Whatever you pay, Sharpy helps you protect muscle on Ozempic with one daily protein target and a 20-minute workout.
What is the Maryland Ozempic price cap? It is a limit of $274 for a 30-day supply of Ozempic that Maryland's state and local government health plans may pay starting January 1, 2027. The state's Prescription Drug Affordability Board gave it final approval on November 16, 2026. It is the first state cap on Ozempic in the US. It does not set your copay, it does not apply to Wegovy, and it is optional for plans until 2028.
Below is a plain-English breakdown of who it covers, why the number is $274, and what you will (and will not) notice at the pharmacy.
Maryland caps Ozempic: the key facts
| Question | Answer |
|---|---|
| Who set it | Maryland Prescription Drug Affordability Board (PDAB) |
| Final vote | November 16, 2026 (an earlier board vote came in May 2026) |
| Drugs covered | Ozempic (semaglutide) and Jardiance (empagliflozin), both for type 2 diabetes |
| Limit | $274 per 30-day supply of Ozempic; $204 per 30-day supply of Jardiance |
| Who must follow it | State and local government health plans in Maryland |
| Start | Optional from January 1, 2027; required after January 1, 2028 |
| Estimated savings | About $6.1 million for state and local governments |
| Not covered | Wegovy, Mounjaro, Zepbound and other GLP-1 drugs |
An "upper payment limit" is the most an eligible plan will pay for a drug. Think of it as a price ceiling for the buyer, not a price tag for you.
Why is the Maryland Ozempic cap $274?
Maryland did not invent the number. Medicare negotiated a price for semaglutide in its second round of drug price talks. Ozempic, Wegovy and Rybelsus were counted together, and the result was $274 for a 30-day supply, starting January 1, 2027. The 2024 list price used in that round was $959, so the negotiated price is about 71% lower.
The board's Ozempic documents tie Maryland's limit to that Medicare price. Governor Wes Moore and some lawmakers now back a bill to let the board link more drugs to Medicare prices.
Novo Nordisk is also cutting the Ozempic list price to $675 a month on January 1, 2027. That is a separate change. Our guide to the Ozempic price cut in 2027 explains who saves from it.
Will Ozempic be cheaper for me in Maryland?
Probably not in a way you see right away. Here is how it breaks down:
| Your situation | Does the cap touch you? |
|---|---|
| Maryland state employee or retiree plan | Yes, if your plan opts in for 2027; required after January 1, 2028 |
| County, city or other local government plan | Same as above |
| Private insurance through a job | Not now; the board may look at the private market starting in 2028 |
| Medicare Part D | No; Medicare's own $274 price starts in 2027 |
| Medicaid | Not named among the plans this cap targets |
| Paying cash | No; cash programs like TrumpRx and NovoCare set their own prices |
Even when your plan uses the cap, your copay or coinsurance is still set by the plan. Reporting from WYPR says patients will not be billed for the gap "in most scenarios," because drugmakers are expected to absorb it.
Could the cap make Ozempic harder to find?
That is the main worry. Some drug companies and patient groups told the board that pharmacies might stop stocking a drug if they cannot buy it at or below the capped price. A patient group called Aimed Alliance also warned about changes to formularies and prior authorization.
The board says it will change the policy if patient access suffers. The only earlier state cap, Colorado's limit on the arthritis drug Enbrel, was blocked by a federal judge after the maker sued. No lawsuit against the Maryland cap had been reported as of November 18, 2026.
If you are on Ozempic through a Maryland government plan, call your pharmacy in December. Ask whether they expect any change in stock for 2027. Do not stop or change your dose because of price news; talk to your prescriber first.
Does Maryland Medicaid cover Ozempic?
Many people searching this news want to know about Medicaid. Ozempic is FDA-approved for adults with type 2 diabetes. State Medicaid programs generally cover diabetes drugs from makers in the federal rebate program, often with prior authorization. Maryland Medicaid members get drugs through managed care plans such as Maryland Physicians Care, so the plan's drug list is the place to check. Coverage of Wegovy for weight loss is a different question; see our guide to Medicaid GLP-1 coverage.
Make each dose count
A lower price does not change what the drug does to your body. In trials, a meaningful share of the weight lost on semaglutide comes from lean mass. Eating enough protein and doing strength work helps keep more of it. See our guide to Ozempic muscle loss for the numbers. Sharpy sets one protein target for the day and one 20-minute workout, so you lose fat, not muscle.
What happens next
- January 1, 2027: Maryland government plans can start using the $274 limit. Medicare's $274 price and Novo Nordisk's $675 list price also start.
- After January 1, 2028: The limit becomes required for state and local government plans.
- 2028: The board may begin setting limits that reach private insurance. Staff estimate that could push yearly savings past $150 million.
The bottom line
The Maryland Ozempic price cap limits what state and local government plans pay to $274 a month, the same as Medicare's 2027 price. It is a first for any state, but it is narrow: no Wegovy, no private plans yet, and no direct change to your copay. Keep an eye on your 2027 plan letters, and keep your focus on the habits you control. Sharpy makes that one protein target and one short workout a day.
Sources
- Maryland Prescription Drug Affordability Board: Upper Payment Limits
- WYPR, Nov 17, 2026: Maryland becomes first state to limit government health plan spending on Ozempic, Jardiance
- Becker's Hospital Review: Maryland sets 1st state payment caps on Ozempic, Jardiance
- Maryland Matters, Nov 16, 2026: Officials give final OK to limit state health plan spending on Ozempic, Jardiance
- STAT, May 18, 2026: Maryland affordability board places a price cap on Ozempic
- AMCP: CMS releases 2027 negotiated prices
Questions people ask
Did Maryland cap the price of Ozempic?
Yes, for government buyers. Maryland's Prescription Drug Affordability Board voted on November 16, 2026 to approve final rules that set an upper payment limit of $274 for a 30-day supply of Ozempic. It is the first state limit of its kind on Ozempic. It covers what state and local government health plans pay, not what every patient pays.
When does the Maryland Ozempic price cap start?
State and local government plans can start using it on January 1, 2027. It becomes required for them after January 1, 2028, according to the board's own website.
Does the Maryland cap apply to Wegovy?
No. The board's vote covers Ozempic and the diabetes drug Jardiance only. Wegovy has the same active ingredient (semaglutide) but is a separate product and is not part of this limit.
Will I pay less for Ozempic in Maryland?
Not directly. The cap sets the most a government plan pays for the drug. Your copay or coinsurance is still set by your plan. Reporting on the rule says patients will not be billed for the gap in most cases; drugmakers are expected to absorb it.
Does Maryland Medicaid cover Ozempic?
Ozempic is approved for type 2 diabetes, and state Medicaid programs generally cover diabetes drugs from companies in the federal rebate program, often with prior authorization. Maryland Medicaid members are served through managed care plans such as Maryland Physicians Care, so call your plan or check its drug list. Medicaid is not named among the plans the new cap targets.
Why $274 for Ozempic?
It matches the price Medicare negotiated for semaglutide (Ozempic, Wegovy and Rybelsus) under the Inflation Reduction Act, which takes effect January 1, 2027. Maryland built its limit on that federal number.